| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0008 |